Curiox Biosystems Co., Ltd (KOSDAQ:445680)
South Korea · Delayed Price · Currency is KRW 48,400
-950 (-1.93%)
At close: Sep 3, 2026
Curiox Biosystems Revenue
Curiox Biosystems had revenue of 1.18B KRW in the quarter ending June 30, 2026, with 18.07% growth. This brings the company's revenue in the last twelve months to 5.73B, up 49.92% year-over-year. In the year 2025, Curiox Biosystems had annual revenue of 5.15B with 12.29% growth.
Revenue (ttm)
5.73B
Revenue Growth
+49.92%
P/S Ratio
142.95
Revenue / Employee
n/a
Employees
n/a
Market Cap
819.74B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.15B | 563.91M | 12.29% |
| Dec 31, 2024 | 4.59B | -2.20B | -32.41% |
| Dec 31, 2023 | 6.79B | -449.07M | -6.21% |
| Dec 31, 2022 | 7.24B | 1.71B | 31.04% |
| Dec 31, 2021 | 5.52B | 1.14B | 25.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Synergy Innovation | 116.56B |
| DENTIS CO.,Ltd | 111.69B |
| Corentec | 104.75B |
| M.I.TECH Co.,Ltd | 70.72B |
| Livsmed | 52.82B |
| BIOBIJOU | 28.56B |
| Sanigen Co. | 14.21B |
| Finemedix | 11.43B |